ASTRO 2022 Virtual Press Room

This page includes news and information from ASTRO Corporate Members and institutions presenting research at the 2022 Annual Meeting. Publication of material on this page does not constitute an endorsement by ASTRO of any product or claim. PR professionals interested in sharing content in the ASTRO Virtual Press Room can view our submission guidelines for Corporate Members and presenting institutions.

(Last updated 10/25/22)

Accuray Incorporated

• Press Release: Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
• Image: Accuray Radixact® System and the C-RAD Catalyst+ Cameras (1)
• Image: Accuray Radixact® System and the C-RAD Catalyst+ Cameras (2)
• Image: Accuray Radixact® System and the C-RAD Catalyst+ Cameras (3)
• Image: Accuray Radixact® System and the C-RAD Catalyst+ Cameras (4)

C-RAD Positioning AB

• Press Release: C-RAD Showcases Advanced SGRT Technologies and Debuts Automated Breast Cancer Treatment Capabilities with Accuray at ASTRO Annual Meeting

CivaTech

• Press Release: CivaSheet shows profound improvement in clinical outcomes for pancreatic cancer patients

Elekta

• Press Release: Elekta increases value-added services and strengthens its position as a life-time companion
• Press Release: Elekta Unity’s motion management capabilities herald a new era in precision radiation therapy

GenesisCare

• Media Alert: Cancer expert gears up for discussions surrounding advanced, personalized treatments for skin cancers at the 2022 ASTRO Annual Meeting
• Media Alert: Cancer expert prepares to discuss digital health innovation, bloodforming cancer, patient support at the 2022 ASTRO Annual Meeting
• Media Alert: Cancer expert to discuss burnout among radiation oncology teams, prostate cancer treatment findings at the 2022 ASTRO Annual Meeting
• Media Alert: Cancer expert to share new treatment findings for patients with early-stage breast cancer, elevated risk of recurrence at the 2022 ASTRO Annual Meeting
• Media Alert: GenesisCare cancer expert moderates discussion on improving patient outcomes through employee engagement, treatment considerations for PSMA-staged high-risk patients at the 2022 ASTRO Annual Meeting

GT Medical Technologies

• Press Release: GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors

RefleXion Medical

• Press Release: RefleXion Highlights New Cancer Treatment Research Abstracts for Presentation at ASTRO 2022
• Fact Sheet: RefleXion Medical Fact Sheet
• Image: RefleXion® X1 machine with SCINTIX™ technology (caption) 

ScandiDos AB

• Press Release: ScandiDos and IBA form a strategic alliance to increase access to safe radiotherapy

Varian

• Press Release: Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

ViewRay

• Press Release: MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022
• Press Release: ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients